It often presents during and after treatment with memory impairment, concentration deficits, and depression. 25.75% prevalence in adolescent and young adult (AYA) cancer survivors. It significantly impacts school, work, daily activities, and overall quality of life.
Retroperitoneal sarcomas (RPS) are rare tumors accounting for 1%–2% of all solid malignancies and 10%–20% of sarcomas. Surgery is the main treatment modality for patients with RPS. To date, there is no established model to predict perioperative risks for RPS patients. In this study, we evaluate the association between preoperative sarcopenia,hypoalbuminemia, and frailty and 30-dayperioperative morbidity and survival in patientswith RPS undergoing surgical resection. Ourgoal is to determine the ability of these factorsto predict surgical and oncological outcomes inthese cases.
A strong predictor of mortality in patients with head and neck cancer (HNC) is the stage of tumor at time of diagnosis. Studies suggest that income level is associated with poor putcomes in HNC patients.
Lung cancer is the leading cause of both cancer and cancer-related mortality in the United States. Targeting different receptor tyrosine kinase pathways has proven to be a potent therapeutic strategy for such cancers.
Lung cancer is the leading cause of cancer related deaths in the US, with 85% of cases classified as non-small cell lung cancer (NSCLC). 20-25% of patients with NSCLC present with resectable disease.
Cancer is the fourth leading cause of death in adolescent and young adults (AYA: ages15-39) worldwide. Over 90% of AYAs with cancer live in low-and-middle-incomecountries (LMIC). Little is known about thecurrent landscape of AYA oncology care in these settings. Guidelines for the care of thisunique population in LMIC in Latin America are lacking.
Endometriosis: ectopic endometrial tissue that responds to cyclical hormonal changes during a normal menstrual cycle, becoming trapped in an endometrioma and causing pain. NHPs have been used to study endometriosis: baboons, cynomolgus, rhesus, and marmoset monkeys.
Compound 10357 is an amiloride derivative with potential promise as an adjunct to current chemotherapeutics. This study investigates the therapeutic efficacy of Compound 10357 in B-Cell Acute Lymphoblastic Leukemia (B-ALL).
Adolescents and young adults (AYAs; 12-25 years old) with cancer are at high risk for elevated distress and poorer mental health outcomes than their peers. Studies have shown that, in particular, Spanish-speaking Latinos with cancer are at risk for increased psychosocial burden, lower quality of life, and higher depressive symptoms when compared to their non-Latino counterparts. Despite this, a systemic review of the literature finds a severe lack of interventional studies being conducted among Hispanic/Latinx cancer patients and survivors. PRISM (Promoting Resilience in Stress Management) is an intervention built on the premise that promoting resilience resources will reduce distress and improve outcomes. However, its efficacy has only been tested in English-speaking populations. Studies show that translating a psychosocial intervention without considering key cultural differences will inevitably be ineffective. The aim of this study is to lay the groundwork for an adaptation of the PRISM intervention for a Spanish-speaking population with an emphasis on promoting engagement and accessibility. In the literature, this process is called cultural attunement. We will focus on the first PRISM module – “Stress Management”
